pharma · Leukemia · Acute Myeloid Leukemia
Shanghai Medical College
Children's Hospital of Fudan University
Shanghai Medical College clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Employees
- 20
- Programs
- 20
- Drugs
- 22
- Patents
- 0
Shanghai Medical College projects
9 ClinicalTrials.gov programs sponsored by Shanghai Medical College.
Shanghai Medical College has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Busulfan
Children's Hospital of Fudan University
Juvenile Myelomonocytic Leukemia
1 trial -
Carboplatin
Children's Hospital of Fudan University
Central Nervous System Nongerminomatous Germ Cell Tumor
1 trial -
Carboplatin
Children's Hospital of Fudan University
Desmoplastic/Nodular Medulloblastoma
1 trial -
Dinutuximab
Children's Hospital of Fudan University
High Risk Neuroblastoma
1 trial -
Doxorubicin Hydrochloride
Children's Hospital of Fudan University
Childhood Renal Cell Carcinoma
1 trial -
bleomycin sulfate
Children's Hospital of Fudan University
Childhood Germ Cell Tumor
1 trial -
radiation therapy
Children's Hospital of Fudan University
Brain Tumor
1 trial -
rituximab
Children's Hospital of Fudan University
Lymphoproliferative Disorder
1 trial -
temozolomide
Children's Hospital of Fudan University
Brain and Central Nervous System Tumors
1 trial
Frequently asked questions
How many clinical projects does Shanghai Medical College have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.